The diagnostic value of serum homocysteine concentration as a risk factor for coronary artery disease

Clinical Chemistry and Laboratory Medicine

Volumn 36, Issue 7, 1998, Pages 453-457

  Dierkes, Jutta ^a,c   Bissé, Emmanuel ^b   Nauck, Matthias ^b   Orth, Matthias ^a,b   Mayer, Horst ^a,b   Luley, Claus ^a,b   Wieland, Heinrich ^b  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c Institute of Clinical Chemistry   (Germany)

Author keywords

Case control study; Coronary artery disease; Hyperhomocysteinemia; Receiver operator characteristic (ROC) analysis

Indexed keywords

CREATININE; CYANOCOBALAMIN; FATTY ACID; FOLIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LIPID; LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AMINO ACID BLOOD LEVEL; ANGIOGRAPHY; AREA UNDER THE CURVE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DIAGNOSTIC VALUE; FATTY ACID BLOOD LEVEL; FOLIC ACID BLOOD LEVEL; HUMAN; LIFESTYLE; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL;

CORONARY DISEASE; DEMOGRAPHY; FOLIC ACID; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; LIFE STYLE; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; ODDS RATIO; QUESTIONNAIRES; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; VITAMIN B 12;

EID: 0031711781     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.1998.076     Document Type: Article

References (20)

1. Pancharuniti N, Lewis CA, Sauberlich HE, Perkins LL, Go RCP, Alvarez JO, et al. Plasma homocyst(e)ine, folate and vitamin B-12 concentrations and risk for early-onset coronary artery disease. Am J Clin Nutr 1994; 59:940-8.
2. Genest JJ, McNamara JR, Salem DN, Wilson PWF, Schaefer EJ, Malinow R. Plasma homocysteine levels in men with premature coronary artery disease. J Am Coll Cardiol 1990; 16:1114-9.
3. Stampfer MJ, Malinow R, Willet WC, Newcomer LM, Upson B, Ullmann D, et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. J Am Med Assoc 1992; 268:877-81.
4. Hopkins PN, Wu LL, Hunt SC, James BC, Vincent GM, Williams RR. Higher plasma homocysteine and increased susceptibility to adverse effects of low folate in early familial coronary artery disease. Arterioscler Thromb Vasc Biol 1995; 15:1314-20.
5. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. J Am Med Assoc 1995; 274:1049-57.
6. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Eng J Med 1991; 324:1149-55.
7. Beck JR, Shultz EK. The use of relative operating characteristic (ROC) curves in test performance evaluation. Arch Pathol Lab Med 1986; 110:13-20.
8. Manual of laboratory operations lipid research clinic program: I. Lipid and Lipoprotein Analysis Department of Health Education and Welfare Publication (NIH) 1974: 75-628.
9. Kröning G, Orth M, Ambrosch A, Witt K, Hass B, Wieland H, Luley C. Turbidimetric determination of Lp(a): lack of interference by plasminogen, lipemia or apo(a) polymorphism. GIT Labormed 1995; 18:220-5.
10. Vester B, Rasmussen K. High performance liquid chromatography method for rapid and accurate determination of homocysteine in plasma and serum. Eur J Clin Chem Clin Biochem 1991; 29:549-54.
11. Selhub J, Jaques PF, Wilson PWF, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. J Am Med Assoc 1993; 270:2693-8.
12. Arnadottir M, Hultberg B, Nilsson-Ehle P, Thysell H. The effect of reduced glomerular filtration rate on plasma total homocysteine concentration. Scand J Clin Lab Invest 1996; 56:41-6.
13. Nygard O, Vollset SW, Refsum H, Stensvold I, Tverdal A, Nordrehaug JE, et al. Total plasma homocysteine and cardiovascular risk profile. The Hordaland homocysteine study. J Am Med Assoc 1995; 1526-33.
14. Ubbink JB, Vermaak WJH, Bennett JB, Becker PJ, van Staden DA, Bissbort S. The prevalence of homocysteinemia and hypercholesterolemia in angiographically defined coronary heart disease. Klin Wochenschr 1991; 69:527-34.
15. Selhub J, Jaques PF, Bostom AG, D'Agostino RB, Wilson PWF, Belanger AJ, et al. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. New Engl J Med 1995; 332:286-91.
16. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997; 337:230-6.
17. Ubbink JB, Vermaak WJ, van der Merve A, Becker PJ, Delport R, Potgieter HC. Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J Nutr 1994; 124:1927-33.
18. Dierkes J, Kroesen M, Pietrzik K. Folic acid and vitamin B6 supplementation and plasma homocysteine concentration in healthy young women. Int J Vit Nutr Res 1998; 68:98-103.
19. Wiklund O, Fager G, Andersson A, Lundstam U, Masson P, Hultberg B. N-acetylcysteine treatment lowers plasma homocysteine but not serum lipoprotein(a) levels. Atherosclerosis 1996; 119:99-106.
20. Ubbink JB, Becker PJ, Vermaak WJH, Delport R. Results of B-vitamin supplementation study used in a prediction model to define a reference range for plasma homocysteine. Clin Chem 1995; 41:1033-7.